Insilico Opens AI Toolkit for Global Longevity Research
Abu Dhabi, UAE, September 17, 2026 Insilico Medicine has announced the global opening of its AI-powered longevity discovery toolkit,...
drug development
Advertisement
Inductive Bio Launches Beacon-2 for AI Drug Discovery
New York, New York, September 17, 2026 Inductive Bio has launched Beacon-2, a new artificial intelligence system designed to...
Aethlon Medical Merges With North Immunology for NOR-101
San Diego, California, and Austin, Texas, September 17, 2026 Aethlon Medical, Inc. and North Immunology, Inc. have announced a...
Novo Nordisk Denecimig Shows Tolerability in Hemophilia A
Plainsboro, New Jersey, and Bagsværd, Denmark, September 17, 2026 Novo Nordisk has announced published Phase 3b results from the...
Teva Launches LongActingImpact.com for Schizophrenia Care
Parsippany, New Jersey, USA & Tel Aviv, Israel, September 16, 2026 Teva Pharmaceuticals has launched LongActingImpact.com, a new educational...
Advertisements
Sling Therapeutics Starts Phase 3 Trial of Linsitinib
Austin, Texas, USA, September 16, 2026 Sling Therapeutics, Inc. has announced that the first patients have been dosed in...
The Braff Group Advises CCR on PhaseWell Partnership
Pittsburgh, Pennsylvania, USA, September 15, 2026 The Braff Group has announced that its client, Community Clinical Research (CCR) of...
Nona Biosciences Develops AI Model for Human Antibodies
Waltham, Massachusetts, USA, September 17, 2026 Nona Biosciences has announced the successful development of what it describes as the...
Sunshine Biopharma Advances PLpro Inhibitor Toward IND
FORT LAUDERDALE, Fla. — September 16, 2026 Sunshine Biopharma Inc. announced that it has advanced its lead Coronavirus drug...
SMSbiotech Advances COPD Program With FDA IND Clearance
United States, September 17, 2026 SMSbiotech has announced that the U.S. Food and Drug Administration (FDA) has cleared its...
Advertisement
